| [1] |
Chen Hongjian, Zhang Suqing.
Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients
[J]. Journal of International Oncology, 2024, 51(6): 344-349.
|
| [2] |
Wang Ying, Liu Nan, Guo Bing.
Advances of antibody-drug conjugate in the therapy of metastatic breast cancer
[J]. Journal of International Oncology, 2024, 51(6): 364-369.
|
| [3] |
Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.
Research progress of habitat analysis in radiomics of malignant tumors
[J]. Journal of International Oncology, 2024, 51(5): 292-297.
|
| [4] |
Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.
Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction
[J]. Journal of International Oncology, 2024, 51(4): 193-197.
|
| [5] |
Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.
Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer
[J]. Journal of International Oncology, 2024, 51(4): 235-238.
|
| [6] |
Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.
Progress of radiotherapy in oligometastatic non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(3): 170-174.
|
| [7] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
| [8] |
Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.
Research progress on the histopathological growth patterns of colorectal liver metastasis
[J]. Journal of International Oncology, 2024, 51(2): 114-118.
|
| [9] |
Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie.
Research progress of myeloid-derived suppressor cells in tumor angiogenesis
[J]. Journal of International Oncology, 2024, 51(1): 50-54.
|
| [10] |
Gu Huayan, Zhu Teng, Guo Guilong.
Breast microbiota and breast cancer： present and future
[J]. Journal of International Oncology, 2024, 51(1): 55-58.
|
| [11] |
Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.
Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2023, 50(8): 475-483.
|
| [12] |
An Rong, Liu Meihua, Wang Peichen, Wang Xiaohui.
Research progress of Nrf2 in ovarian cancer
[J]. Journal of International Oncology, 2023, 50(8): 493-497.
|
| [13] |
Wang Wende, Zeng De.
Research progress on the mechanism of endocrine therapy resistance for breast cancer
[J]. Journal of International Oncology, 2023, 50(6): 352-356.
|
| [14] |
Yang Lirong, Wang Yufeng.
Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer
[J]. Journal of International Oncology, 2023, 50(4): 220-226.
|
| [15] |
Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.
Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance
[J]. Journal of International Oncology, 2023, 50(4): 227-230.
|
